SEVENTH GENERATION

Seventh Generation specializes in unscented menstrual hygiene products, specifically disposable menstrual pads and tampons. These devices are designed for single-use personal hygiene during menstruation and are marketed without added fragrances. The company focuses exclusively on these categories, ensuring compliance with regulatory standards for Class I and Class II devices.

Seventh Generation is based in the United States. Since the company operates within the U.S., its devices are subject to FDA regulations. The FDA’s Unique Device Identifier (UDI) database includes listings for Seventh Generation’s products, which helps track and monitor these devices under U.S. regulatory frameworks. The location also influences classification, as the FDA determines whether a device falls under Class I or Class II based on its risk profile and intended use.

Seventh Generation’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is critical because it provides a standardized way to identify medical devices throughout their lifecycle, from manufacturing to post-market surveillance. Listing in the UDI database ensures traceability, supports regulatory compliance, and enables healthcare providers, distributors, and patients to access accurate information about the devices, including their classification (Class I or Class II) and intended use.

Seventh Generation’s menstrual pads and tampons are classified as either Class I or Class II devices. The classification depends on factors like the device’s risk level, intended use, and potential impact on patient safety. Class I devices generally pose minimal risk and may require general controls, while Class II devices involve a higher level of risk and may require special controls to ensure safety and effectiveness. The FDA determines these classifications to guide regulatory oversight and compliance requirements.